Suture Button vs Fibulink Fixation for Ankle Injury
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to compare two surgical methods for treating ankle injuries requiring surgery. Participants will receive either a suture button (Arthrex Tightrope) or a Fibulink implant (Synthes Fibulink) to repair the syndesmosis, a joint area in the ankle. Researchers will observe pain levels, recovery time, and overall ankle function to determine which method is more effective. This trial suits individuals with an ankle fracture and a syndesmotic injury needing surgery who can understand the consent information. As an unphased trial, it offers participants the chance to contribute to valuable research that could enhance future treatment options for ankle injuries.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the study team or your doctor.
What prior data suggests that these fixation methods are safe for ankle injuries?
Research has shown that both Arthrex Tightrope and Synthes Fibulink are generally safe for treating ankle injuries. The Arthrex Tightrope stabilizes the ankle and often remains in place without removal. Studies have found it supports quick recovery, allowing people to resume activities in less than two months, with no major safety concerns reported.
The Synthes Fibulink system allows the ankle to move naturally. Research indicates that it enables early weight-bearing without causing additional problems, suggesting it is safe and aids in effective healing.
Both treatments are promising for safety and effectiveness, making them good options for managing ankle injuries.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for ankle injuries because they offer innovative approaches to syndesmosis fixation. The Arthrex Tightrope uses a high-tension suture with a button-based anchor system, which provides flexibility and potentially less irritation compared to traditional metal screws. On the other hand, the Synthes Fibulink employs a screw-based anchor system, known for robust stabilization. These methods aim to improve patient outcomes by offering alternatives to the standard metallic screw fixation, promising enhanced stability or reduced complications in ankle injury recovery.
What evidence suggests that this trial's treatments could be effective for ankle syndesmosis injuries?
Research has shown that the Arthrex Tightrope, one of the treatments in this trial, effectively stabilizes ankle injuries. It often results in fewer surgeries and complications for patients by reducing the need to remove implants compared to traditional screws. The Synthes Fibulink system, another treatment option in this trial, is designed to maintain proper alignment of ankle bones after an injury. Early studies suggest that Fibulink offers strong and stable support. Both treatments in this trial aim to enhance recovery and outcomes for ankle injuries.16789
Are You a Good Fit for This Trial?
This trial is for adults over 18 with an acute ankle syndesmosis injury that needs surgery. Candidates must understand the consent form and can't be in another drug study, imprisoned, pregnant, have severe systemic disease not managed medically, or prefer a specific implant.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo surgical fixation with either a suture button or Fibulink implant for acute ankle syndesmosis injuries
Follow-up
Participants are monitored for safety and effectiveness, including pain, range of motion, and functional scores
What Are the Treatments Tested in This Trial?
Interventions
- Arthrex Tightrope
- Synthes Fibulink
Arthrex Tightrope is already approved in United States for the following indications:
- Ankle syndesmosis injuries
- Ankle fractures with syndesmosis disruption
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Diego
Lead Sponsor